More on ROG
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $109.42 |
|
|||
| Open | $105.35 | ||||
| 52 Wk High | $76.55 | ||||
| 52 Wk Low | $41.92 | ||||
| Day High | $106.91 | ||||
| Day Low | $101.77 | ||||
| P/E | 58.52 | ||||
| EPS | $1.77 | ||||
| Volume | 161,218 | ||||
- New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
- Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Form 8-K ROGERS CORP For: Mar 02
- Form 4 ROGERS CORP For: Feb 28 Filed by: Tsao Jeff
- Form 4 ROGERS CORP For: Feb 28 Filed by: Russell Laura
- Form 4 ROGERS CORP For: Feb 28 Filed by: Reeder Raymond Sean
- Form 4 ROGERS CORP For: Feb 28 Filed by: Morton Jessica Ann
- Form 4 ROGERS CORP For: Feb 28 Filed by: Larabee Brian Keith
- Form 4 ROGERS CORP For: Feb 28 Filed by: Webb Michael Reed
Entities mentioned with ROG
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
